Peter Jantscheff

1.6k total citations
40 papers, 1.3k citations indexed

About

Peter Jantscheff is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter Jantscheff has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Immunology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter Jantscheff's work include Virus-based gene therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and CAR-T cell therapy research (8 papers). Peter Jantscheff is often cited by papers focused on Virus-based gene therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and CAR-T cell therapy research (8 papers). Peter Jantscheff collaborates with scholars based in Germany, Switzerland and France. Peter Jantscheff's co-authors include Ulrich Massing, Nicolas Barnich, Harald Peeters, Frédéric A. Carvalho, Jean‐Frédéric Colombel, Pierre Desreumaux, Matthieu Allez, Anne-Lise Glasser, Arlette Darfeuille–Michaud and Claude Darcha and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Peter Jantscheff

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Jantscheff Germany 20 600 359 303 228 183 40 1.3k
Allan Jensen United States 21 555 0.9× 169 0.5× 158 0.5× 289 1.3× 547 3.0× 37 1.6k
Kenichiro Ito Japan 24 897 1.5× 217 0.6× 107 0.4× 126 0.6× 132 0.7× 65 1.6k
Tony Purchio United States 12 811 1.4× 187 0.5× 168 0.6× 98 0.4× 106 0.6× 12 1.4k
David Ruano‐Gallego Spain 17 487 0.8× 140 0.4× 240 0.8× 118 0.5× 131 0.7× 30 946
Ping Tsui United States 23 902 1.5× 169 0.5× 314 1.0× 364 1.6× 486 2.7× 53 1.8k
Saeed Khalili Iran 24 857 1.4× 272 0.8× 73 0.2× 359 1.6× 283 1.5× 97 1.7k
Barrett R. Harvey United States 21 558 0.9× 113 0.3× 125 0.4× 94 0.4× 364 2.0× 26 1.1k
Purnima Dubey United States 20 556 0.9× 487 1.4× 166 0.5× 583 2.6× 86 0.5× 45 1.5k
Madiha Derouazi Switzerland 21 749 1.2× 253 0.7× 366 1.2× 359 1.6× 90 0.5× 35 1.2k
Paul Costeas Cyprus 19 411 0.7× 197 0.5× 144 0.5× 316 1.4× 26 0.1× 47 1.4k

Countries citing papers authored by Peter Jantscheff

Since Specialization
Citations

This map shows the geographic impact of Peter Jantscheff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jantscheff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jantscheff more than expected).

Fields of papers citing papers by Peter Jantscheff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Jantscheff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jantscheff. The network helps show where Peter Jantscheff may publish in the future.

Co-authorship network of co-authors of Peter Jantscheff

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Jantscheff. A scholar is included among the top collaborators of Peter Jantscheff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Jantscheff. Peter Jantscheff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jantscheff, Peter, T Ross, Martin Schlesinger, et al.. (2015). Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases. Lipids in Health and Disease. 14(1). 69–69. 60 indexed citations
2.
Jantscheff, Peter, Martin Schlesinger, Lenka A. Taylor, et al.. (2011). Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion In vitro and Inhibits Metastasis-Like Lung Invasion In vivo. Molecular Cancer Therapeutics. 10(1). 186–197. 44 indexed citations
3.
Alexander, M. Yvonne, Martin Schlesinger, Peter Jantscheff, Ulrich Massing, & Gerd Bendas. (2010). Reduction in human melanoma cell adhesion receptor activity by lysophosphatidylcholine (LPC) treatment – functional characterization and signal pathway analyses. International Journal of Clinical Pharmacology and Therapeutics. 48(7). 478–480. 1 indexed citations
4.
Graeser, Ralph, N. Esser, Vittorio Ziroli, et al.. (2009). Antimetastatic Effects of Liposomal Gemcitabine and Empty Liposomes in an Orthotopic Mouse Model of Pancreatic Cancer. Pancreas. 38(3). 330–337. 52 indexed citations
5.
Jantscheff, Peter, Vittorio Ziroli, N. Esser, et al.. (2009). Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model. Clinical & Experimental Metastasis. 26(8). 981–992. 29 indexed citations
6.
Geipel, Andreas, Frank Goldschmidtboeing, Peter Jantscheff, et al.. (2008). Design of an implantable active microport system for patient specific drug release. Biomedical Microdevices. 10(4). 469–478. 21 indexed citations
7.
Geipel, Andreas, Cecília Farhat, Peter Jantscheff, et al.. (2007). Biocompatible polymer encapsulation with embedded functional structures for medical devices. 272–276. 1 indexed citations
8.
Barnich, Nicolas, Frédéric A. Carvalho, Anne-Lise Glasser, et al.. (2007). CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. Journal of Clinical Investigation. 117(6). 1566–1574. 444 indexed citations
9.
Jantscheff, Peter, et al.. (2002). Combinatorial Synthesis of New Cationic Lipids and High-Throughput Screening of Their Transfection Properties. ChemBioChem. 3(9). 852–858. 28 indexed citations
10.
Rochlitz, Christoph, Brigitte Dréno, Peter Jantscheff, et al.. (2002). Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels. Cancer Gene Therapy. 9(3). 289–295. 27 indexed citations
11.
Jantscheff, Peter, Giulio C. Spagnoli, Paul Zajac, & Christoph Rochlitz. (2002). Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells. Cancer Immunology Immunotherapy. 51(7). 367–375. 33 indexed citations
12.
Jantscheff, Peter, Luigi Terracciano, Katharina Glatz‐Krieger, et al.. (2001). Expression of CEACAM6 in colorectal cancer: significant association with overall and disease-free survival. European Journal of Cancer. 37. S290–S290. 3 indexed citations
13.
Tartour, Éric, Majid Mehtali, Xavier Sastre‐Garau, et al.. (2000). Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings. British Journal of Cancer. 83(11). 1454–1461. 19 indexed citations
14.
Donda, Alena, Lucia Mori, Abdijapar Shamshiev, et al.. (2000). Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell response. European Journal of Immunology. 30(9). 2593–2603. 42 indexed citations
15.
Jantscheff, Peter, Richard Herrmann, & Christoph Rochlitz. (1999). Cancer gene and immunotherapy: recent developments. Medical Oncology. 16(2). 78–85. 13 indexed citations
16.
Rochlitz, Christoph, Peter Jantscheff, G. Bongartz, et al.. (1999). Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumors. Cancer Gene Therapy. 6(3). 271–281. 19 indexed citations
17.
Rochlitz, Christoph, Peter Jantscheff, G. Bongartz, et al.. (1998). Gene Therapy with Cytokine-Transfected Xenogeneic Cells in Metastatic Tumors. Advances in experimental medicine and biology. 451. 531–537. 7 indexed citations
18.
Grunert, Fritz, et al.. (1995). CD66b, CD66c and carcinoembryonic antigen (CEA) are independently regulated markers in sera of tumor patients. International Journal of Cancer. 63(3). 349–355. 12 indexed citations
19.
Jantscheff, Peter, et al.. (1993). Hybrid hybridomas producing bispecific antibodies to CEA and peroxidase isolated by a combination of HAT medium selection and fluorescence activated cell sorting. Journal of Immunological Methods. 163(1). 91–97. 22 indexed citations
20.
Nagel, G., Jennifer Johnson, Francis M. Lobo, et al.. (1993). Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants. International Journal of Cancer. 55(2). 303–310. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allan Jensen Breakdown of academic impact, for papers by Kenichiro Ito Breakdown of academic impact, for papers by Tony Purchio Breakdown of academic impact, for papers by David Ruano‐Gallego Breakdown of academic impact, for papers by Ping Tsui Breakdown of academic impact, for papers by Saeed Khalili Breakdown of academic impact, for papers by Barrett R. Harvey Breakdown of academic impact, for papers by Purnima Dubey Breakdown of academic impact, for papers by Madiha Derouazi Breakdown of academic impact, for papers by Paul Costeas
Rankless by CCL
2026